期刊
PHYTOTHERAPY RESEARCH
卷 33, 期 8, 页码 2118-2125出版社
WILEY
DOI: 10.1002/ptr.6406
关键词
hesperidin; inflammation; insulin resistance; liver enzymes; liver steatosis; nonalcoholic fatty liver disease
This study aimed to evaluate the effects of hesperidin on nonalcoholic fatty liver disease (NAFLD) characteristics. In this randomized, double-blind, controlled clinical trial, 50 NAFLD patients were supplemented with either 1-g hesperidin capsule or identical placebo capsule for 12 weeks. During the intervention, both groups were advised to follow healthy lifestyle habits including dietary and physical activity recommendations. At the end of the study, hesperidin supplementation, compared with placebo, was associated with a significant reduction in alanine aminotransferase (p = .005), gamma-glutamyltransferase (p = .004), total cholesterol (p = .016), triglyceride (p = .049), hepatic steatosis (p = .041), high-sensitivity C-reactive protein (p = .029), tumor necrosis factor-alpha, and nuclear factor-kappa B (NF-kappa B). In conclusion, our results indicate that hesperidin supplementation accompanied with lifestyle modification is superior to lifestyle modification alone in management of NAFLD at least partially through inhibiting NF-kappa B activation and improving lipid profile. Further studies with higher dose of hesperidin are required to find the optimal dose.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据